Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC known ✓ | P12931 | 1/20 | 0.41 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.46 |
| ▸ | C1S | P09871 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | F12 | P00748 | 1/20 | 0.44 |
| ▸ | F7 | P08709 | 1/20 | 0.44 |
| ▸ | F3 | P13726 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL441069 | 0.97 | TSHR (0.52) | TSHRBLMKMT2APRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL1821949 | 0.93 | TSHR (0.48) | TSHRBLMKMT2APRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL10515151 | 0.87 | WDR5 (0.52) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11308665 | 0.83 | TSHR (0.45) | TSHRBLMKMT2AF2F10 | |
| SCHEMBL14269665 | 0.79 | PRSS1 (0.58) | KMT2APRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL8259804 | 0.78 | TSHR (0.43) | TSHRBLMKMT2APRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL11615422 | 0.78 | TDP1 (0.52) | KMT2APKMCES1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL561736 | 0.78 | CA12 (0.52) | TSHRBLMKMT2ARECQLF12 | |
| Hydrochloric Acid SCHEMBL6643309 | 0.77 | BLM (0.50) | TSHRBLMKMT2APRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL26618193 | 0.77 | TSHR (0.41) | TSHRBLMKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708838-B2 | Chemical sequestration of wellbore fluids in electric submersible pump systems | HALLIBURTON ENERGY SERVICES, INC. (US) | 2023-07-25 | — | — | US | claimed |
| US-20220003240-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. | 2022-01-06 | — | — | US | claimed |
| WO-2022005484-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2022-01-06 | — | — | WO | claimed |
| CN-101591265-B | Method for preparing benzyl imine methyl ether hydrochloride | ZHUHAI UNITED LAB CO LTD | 2013-06-05 | — | — | CN | claimed |
| CN-101591265-A | A kind of preparation method of benzyl imine methyl ether hydrochloride | ZHUHAI UNITED LAB CO LTD (CN) | 2009-12-02 | — | — | CN | claimed |
| US-11708838-B2 | Chemical sequestration of wellbore fluids in electric submersible pump systems | HALLIBURTON ENERGY SERVICES, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20220003240-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. | 2022-01-06 | — | — | US | disclosed |
| WO-2022005484-A1 | CHEMICAL SEQUESTRATION OF WELLBORE FLUIDS IN ELECTRIC SUBMERSIBLE PUMP SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2022-01-06 | — | — | WO | disclosed |
| US-11026936-B2 | Piperidinyl-propanone derivatives | MERCK PATENT GMBH (DE) | 2021-06-08 | — | — | US | disclosed |
| US-20200253949-A1 | PIPERIDINYL-PROPANONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| EP-3436443-B1 | N1-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPIONYL)-PIPERIDINE DERIVATIVES AS INHIBITORS OF PYRUVATE DEHYDROGENASE KINASE | MERCK PATENT GMBH (DE) | 2020-03-11 | — | — | EP | disclosed |
| EP-3436443-A1 | N1-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPIONYL)-PIPERIDINE DERIVATIVES AS INHIBITORS OF PYRUVATE DEHYDROGENASE KINASE | Merck Patent GmbH (DE) | 2019-02-06 | — | — | EP | disclosed |
| US-5300477-A | 2-arylpyrimidines and herbicidal use thereof | ROHM AND HAAS COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0579424-A1 | 2-substituted pyrimidines and herbicidal use thereof | ROHM AND HAAS COMPANY (US) | 1994-01-19 | — | — | EP | disclosed |
| US-5208228-A | Skin disorders | MERCK & CO., INC. (US) | 1993-05-04 | — | — | US | disclosed |
| EP-0530888-A1 | Fluoromacrolides having immunosuppressive activity | MERCK & CO. INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| US-5189042-A | Treating autoimmune diseases, preventing transplant rejection | MERCK & CO. INC. (US) | 1993-02-23 | — | — | US | disclosed |
| US-5047570-A | Reacting nitrile with alkanol inpresence of hydrogen halide, then with malodinitrile | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| EP-0428365-A1 | Aminomacrolides and derivatives having immunosuppressive activity | MERCK & CO. INC. (US) | 1991-05-22 | — | — | EP | disclosed |
| US-4808530-A | Protein immobilization by adsorption of a hydrophobic amidine protein derivative to a hydrophobic surface | THE OHIO STATE UNIVERSITY (US) | 1989-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11026936-B2 | Piperidinyl-propanone derivatives | PDK2, PDK3, PDK1 | SRC 3645/4885SLC6A3 4146/4885TSHR 3297/4885 |
| US-20200253949-A1 | PIPERIDINYL-PROPANONE DERIVATIVES | PDK2, PDK3, PDK1 | SRC 3645/4885SLC6A3 4146/4885TSHR 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.